ARTICLE | Company News
Acadia, Allergan deal
May 15, 2006 7:00 AM UTC
The companies extended through March 2008 their 2003 deal to develop therapeutics to treat neuropathic pain. They have an undisclosed agonist of adrenergic receptor alpha in Phase II testing. ...